Hypersensitivity of MAIT cells to Leukocidin ED indicates a Staphylococcus aureus immune evasion mechanism targeting the innate effector cell response

Abstract

Mucosa-associated invariant T (MAIT) cells recognize bacterial riboflavin metabolite antigens presented by MR1 and play an important role in antimicrobial immune defense. Staphylococcus aureus is a pathobiont expressing a range of virulence factors including the secreted toxin Leukocidin ED (LukED), which binds to certain chemokine receptors and causes cell death by osmolysis. Here, we investigated the effect of LukED on subsets of human T cells and NK cells that are involved in the early innate response to infection. MAIT cells were strikingly hypersensitive to LukED-mediated lysis and rapidly lost from the peripheral blood T cell pool upon exposure to the toxin, leaving a T cell population devoid of MAIT cells. The cytolytic effect of LukED on MAIT cells was rapid, occurred at lower LukED concentration compared to effects on the overall T cell pool, and coincided with extraordinarily high and uniform expression of CCR5. Furthermore, loss of MAIT cells was efficiently inhibited by the CCR5 inhibitor Maraviroc. Interestingly, pre-activation of MAIT cells with IL-12 and IL-18 also partially rescued these cells from LukED toxicity. Among NK cells, LukED targeted the more mature and cytotoxic CD57+ NK cell subset in a CXCR1-dependent manner. Overall, these results indicate that LukED efficiently eliminates cells of the human immune system that have the capacity to respond rapidly to S. aureus in an innate fashion, and that MAIT cells are exceptionally vulnerable to this toxin. Thus, the findings support a model where LukED functions as a S. aureus immune evasion mechanism to avoid recognition by the rapid cell-mediated responses mediated by MAIT cells and NK cells.